We are live on ! Find out more
XT

XTX Topco Portfolio holdings

AUM $5.75B
1-Year Est. Return 30.56%
This Fund
S&P 500
This Quarter Est. Return
+0.17%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$3.81B
AUM Growth
+$1.88B
Cap. Flow
+$1.94B
Cap. Flow %
50.99%
Top 10 Hldgs %
5.52%
Holding
3,983
New
1,493
Increased
1,108
Reduced
652
Closed
727

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$25.6M
2
JPM icon
JPMorgan Chase
JPM
+$21.7M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$19.7M
4
KR icon
Kroger
KR
+$17.9M
5
TMUS icon
T-Mobile US
TMUS
+$15.8M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$11.3M
2
TMO icon
Thermo Fisher Scientific
TMO
+$8.42M
3
BMY icon
Bristol-Myers Squibb
BMY
+$8.34M
4
CSCO icon
Cisco
CSCO
+$8.02M
5
QQQ icon
Invesco QQQ Trust
QQQ
+$8.01M

Sector Composition

Rank Sector Weight
1 Financials 16.84%
2 Technology 16.54%
3 Industrials 11.45%
4 Healthcare 11.32%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GUTS icon
2601
Fractyl Health
GUTS
$109M
$114K ﹤0.01%
51,932
+5,885
+13% +$9.47K
FLWS icon
2602
1-800-Flowers.com
FLWS
$252M
$114K ﹤0.01%
28,959
-75,425
-72% -$296K
HITI
2603
High Tide
HITI
$180M
$113K ﹤0.01%
42,606
+11,222
+36% +$33.3K
LOCO icon
2604
El Pollo Loco
LOCO
$503M
$112K ﹤0.01%
+10,711
New +$111K
MGX icon
2605
Metagenomi Therapeutics
MGX
$45.6M
$112K ﹤0.01%
68,994
+53,778
+353% +$116K
BBBY
2606
Bed Bath & Beyond
BBBY
$479M
$112K ﹤0.01%
20,465
-37,234
-65% -$270K
NPWR icon
2607
NET Power
NPWR
$120M
$111K ﹤0.01%
48,802
-35,950
-42% -$112K
LXEO icon
2608
Lexeo Therapeutics
LXEO
$338M
$111K ﹤0.01%
11,144
-15,571
-58% -$142K
LXRX icon
2609
Lexicon Pharmaceuticals
LXRX
$1.03B
$111K ﹤0.01%
96,090
-233,446
-71% -$321K
MVT
2610
DELISTED
BlackRock MuniVest Fund II
MVT
$110K ﹤0.01%
+10,199
New +$109K
GGLS icon
2611
Direxion Daily GOOGL Bear 1X ETF
GGLS
$15.2M
$109K ﹤0.01%
+1,610
New +$122K
UP icon
2612
Wheels Up
UP
$203M
$109K ﹤0.01%
8,312
+7,781
+1,465% +$177K
POM
2613
Pomdoctor Ltd
POM
$5.22M
$109K ﹤0.01%
+20,520
New +$1.34M
ORMP icon
2614
Oramed Pharmaceuticals
ORMP
$162M
$109K ﹤0.01%
38,182
+14,297
+60% +$36.9K
DGNX
2615
Diginex Ltd
DGNX
$45.1M
$108K ﹤0.01%
3,250
+1,292
+66% +$143K
DPRO
2616
Draganfly
DPRO
$140M
$108K ﹤0.01%
+15,586
New +$132K
ARKO icon
2617
ARKO Corp
ARKO
$868M
$108K ﹤0.01%
23,703
+4,415
+23% +$19.8K
INMB icon
2618
INmune Bio
INMB
$44.9M
$107K ﹤0.01%
68,865
+20,121
+41% +$35.9K
POWW icon
2619
Outdoor Holding Co
POWW
$249M
$107K ﹤0.01%
62,773
-107,906
-63% -$186K
EM
2620
DELISTED
Smart Share Global Ltd
EM
$107K ﹤0.01%
91,261
+20,642
+29% +$27.5K
FCT
2621
First Trust Senior Floating Rate Income Fund II
FCT
$251M
$107K ﹤0.01%
+10,587
New +$103K
CMTL icon
2622
Comtech Telecommunications
CMTL
$49.7M
$106K ﹤0.01%
20,043
-16,339
-45% -$53.3K
GRCE
2623
Grace Therapeutics
GRCE
$33.8M
$106K ﹤0.01%
+30,261
New +$96.1K
AHMA
2624
Ambitions Enterprise Management Co
AHMA
$41.3M
$106K ﹤0.01%
+21,361
New +$136K
NEPH icon
2625
Nephros
NEPH
$35.2M
$105K ﹤0.01%
21,617
+7,062
+49% +$36.1K
103 104
105
106 107

Similar funds

HW
Hancock Whitney Gulfport, Mississippi $5.75B AUM 24.3% 1-Year Est. Return
AAM
Alphadyne Asset Management New York $5.76B AUM 22.07% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $5.76B AUM 24.57% 1-Year Est. Return
SAM
Scopus Asset Management New York $5.77B AUM 36.85% 1-Year Est. Return
PP
Peconic Partners New York $5.78B AUM 127.23% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return

XTX Topco's Q4 2025 Portfolio in Review

As of Q4 2025, XTX Topco held 3,983 positions worth $3.81B, up 98% from $1.93B the previous quarter. Its ten largest holdings account for 5.5% of the portfolio.

XTX Topco deployed $1.94B of net new capital in Q4 2025, opening 1,493 new positions and adding to 1,108 existing holdings. Its largest new stake was T-Mobile US: 74,738 shares worth $15.2M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 14% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $8.34M trimmed.

  • XTX Topco's largest Q4 2025 buy was T-Mobile US: 74,738 shares worth $15.2M.
  • XTX Topco added most to Procter & Gamble in Q4 2025, an estimated $25.6M increase.
  • XTX Topco's biggest Q4 2025 reduction was Bristol-Myers Squibb, cutting an estimated $8.34M.
  • XTX Topco fully exited Johnson & Johnson in Q4 2025, selling an estimated $11.3M.
  • XTX Topco's ten largest holdings make up 5.5% of its $3.81B portfolio in Q4 2025.
  • XTX Topco opened 1,493 new positions and closed 727 in Q4 2025.
  • XTX Topco's portfolio value rose 98% quarter-over-quarter to $3.81B.

Based on XTX Topco's 13F filing for Q4 2025, filed 17 Feb 2026.